Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

Glutsch, Valerie; Schummer, Patrick; Kneitz, Hermann; Gesierich, Anja; Goebeler, Matthias; Klein, Detlef; Posch, Christian; Gebhardt, Christoffer; Haferkamp, Sebastian; Zimmer, Lisa; Becker, Juergen C.; Leiter, Ulrike; Weichenthal, Michael; Schadendorf, Dirk; Ugurel, Selma; Schilling, Bastian

dc.contributor.author	Leiter-Stöppke, Ulrike
dc.date.accessioned	2023-05-16T08:47:55Z
dc.date.available	2023-05-16T08:47:55Z
dc.date.issued	2022
dc.identifier.issn	2051-1426
dc.identifier.uri	http://hdl.handle.net/10900/141173
dc.language.iso	en	de_DE
dc.publisher	Bmj Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1136/jitc-2022-005930	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230202000000_00613
utue.personen.roh	Glutsch, Valerie
utue.personen.roh	Schummer, Patrick
utue.personen.roh	Kneitz, Hermann
utue.personen.roh	Gesierich, Anja
utue.personen.roh	Goebeler, Matthias
utue.personen.roh	Klein, Detlef
utue.personen.roh	Posch, Christian
utue.personen.roh	Gebhardt, Christoffer
utue.personen.roh	Haferkamp, Sebastian
utue.personen.roh	Zimmer, Lisa
utue.personen.roh	Becker, Juergen C.
utue.personen.roh	Leiter, Ulrike
utue.personen.roh	Weichenthal, Michael
utue.personen.roh	Schadendorf, Dirk
utue.personen.roh	Ugurel, Selma
utue.personen.roh	Schilling, Bastian
dcterms.isPartOf.ZSTitelID	Journal For Immunotherapy of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	Article e005930	de_DE
dcterms.isPartOf.ZS-Volume	10 (11)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE